Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 18, 2020
Monoclonal antibody extravasations: Two case reports and literature reviewAlicia Rodríguez-Alarcón, David Conde-Estévez
International Journal of Clinical Pharmacy|October 17, 2013
Survey of oral chemotherapy safety and adherence practices of hospitals in SpainDavid Conde-Estévez, Esther Salas, Joan Albanell
The Journal of Antimicrobial Chemotherapy|February 18, 2022
Impact of drug safety warnings and antimicrobial stewardship programme implementation on tigecycline prescribing: a prospective quasi-experimental interrupted time series analysisMelisa Barrantes-González, Santiago Grau, David Conde-Estévez
Journal of Chemotherapy (Florence, Italy)|June 5, 2015
Hypersensitivity reaction caused by folinic acid administration: a case report and literature reviewMarta Florit-Sureda, David Conde-Estévez, Joana Vidal, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|January 14, 2021
Effectiveness and safety of a novel dexamethasone mouthwash formulation in managing stomatitis in cancer patientsXènia Fernández-Sala, Jaime Barceló-Vidal, Ignasi Tusquets, et al.
Anti-Cancer Drugs|July 31, 2010
Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicinDavid Conde-Estévez, Silvia Saumell, Antonio Salar, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 16, 2022
Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug-drug interactionsDavid Conde-Estévez, Iván Henríquez, Jesús Muñoz-Rodríguez, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|January 9, 2014
[Influence of ethnicity on the pharmacokinetics of amikacin]Melisa Barrantes-González, Santiago Grau, David Conde-Estévez, et al.
Anti-Cancer Drugs|June 4, 2014
An overview of randomized clinical trials in metastatic breast cancer: variables affecting regulatory drug approvalDavid Conde-Estévez, Ignasi Tusquets, Sonia Servitja, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 26, 2020
Breast cancer, placing drug interactions in the spotlight: is polypharmacy the cause of everything?José Alberto Domínguez-Alonso, David Conde-Estévez, David Bosch, et al.
Pageof 2